The abstract is read at the publisher; the summary is JClub's.
Circulating tumour-derived extracellular matrix fragment fingerprints detect protease-generated collagen, proteoglycan, and glycoprotein neo-epitopes with exceptional sensitivity and specificity.
- Why it matters: Tumour progression disrupts extracellular matrix homeostasis, creating molecular signatures that can reflect cancer, stromal fibroblast, and immune activity beyond genomic readouts.
- What they did: Using recent neo-epitope detection platform advances, researchers measure specific ECM fragments as dynamic, real-time indicators of microenvironmental remodelling across the cancer continuum.
- The result: ECM fragment fingerprints are linked to tracking disease activity, distinguishing malignancy from benign conditions in early detection, stratifying aggressiveness beyond anatomical staging, monitoring treatment response, and predicting immunotherapy efficacy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.